Fulcrum Capital’s Colgate-Palmolive CL Stock Holding History

Fulcrum Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,700	Closed	-$204K	–	71
2017 Q4	$204K	Buy	+2,700	New	+$197K	0.07%	73

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fulcrum Capital's CL Position: Q1 2018 in Review

Fulcrum Capital sold out of Colgate-Palmolive (CL) in Q1 2018, closing a stake of 2,700 shares — an estimated $204K sold.

Fulcrum Capital first reported a position in CL in Q4 2017 and held it in 1 quarter. The position peaked at $204K in Q4 2017. 1,439 funds tracked by Wall St. Rank hold CL as of Q1 2018.

Fulcrum Capital reported no remaining Colgate-Palmolive position as of Q1 2018 after selling out during the quarter.
Fulcrum Capital sold 2,700 Colgate-Palmolive shares in Q1 2018, an estimated $204K.
Fulcrum Capital first reported a position in Colgate-Palmolive in Q4 2017 and held it in 1 quarter.
Fulcrum Capital's Colgate-Palmolive position peaked at $204K in Q4 2017.
1,439 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2018.

Based on Fulcrum Capital's 13F filing for Q1 2018, filed 9 May 2018.